Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity
Nehad S. El Salamouni, Benjamin J. Buckley, Marie Ranson, Michael J. Kelso, Haibo Yu
Topics & Concepts
AmilorideUrokinasePlasminogen activatorPharmacologyChemistryMetastasisMedicineCancerInternal medicineSodiumOrganic chemistryProtease and Inhibitor MechanismsBlood Coagulation and Thrombosis MechanismsPeptidase Inhibition and Analysis